Company / Capital Returned to Shareholders
Doximity Capital Returned to Shareholders History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$120.3M
FY2024
5-year range
$2.7M / $280.7M
FY2020-FY2024
Trend
-57.1%
vs FY2023
Sector context
#55 of 103
Health Care
What the data says
At $120M, Doximity's capital returned to shareholders ranks #55 of 103 in the Health Care sector. Improved from $85M to $120M over the past 2 years.
Based on SEC 10-K filings.
$120M in FY2024 with a 3-year CAGR of +254.6%.
Improved from $85M to $120M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +254.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#55 of 103 in Health CareTop 53% of 103This company $120.3M Sector average $721.8M
▼
-83.3% below sector average
Key checks
Key Insights
- 3-year CAGR of +254.6%, indicating consistent growth.
- In FY2024, capital returned to shareholders decreased 57.1% year-over-year.
- Ranks #55 out of 103 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $120.3M | -57.1% |
| FY2023 | $280.7M | +229.0% |
| FY2022 | $85.3M | +3062.5% |
| FY2021 | $2.7M | +33.4% |
| FY2020 | $2.0M | - |
| FY2019 | $0 | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026